02. Bright Light Therapy for Bipolar Depression: ISBD Clinical Recommendations

Text version

Bright Light Therapy for Bipolar Depression

We all know bipolar disorder can be tough to treat. But people with it spend far more time in depression than mania. Bipolar depression significantly diminishes quality of life, leads to functional and cognitive impairments, and increases suicide risk. Our first-line treatments often have limited efficacy or come with major side effects.

That’s why I’m so excited to talk about a growing body of evidence supporting an intervention that is often underutilized and sometimes misunderstood: bright light therapy (BLT). Today, we’re diving into the recent comprehensive review and clinical recommendations from the International Society for Bipolar Disorders (ISBD) Chronobiology and Chronotherapy Task Force. This paper is a game changer aiming to bridge the gap between research and clinical application and I believe it’s essential for all clinicians who see mental health patients, not just bipolar experts.

BLT: Mechanism of Action

Historically, the connection between light and mood dates back to ancient times with Hippocrates advocating heliotherapy, sunlight therapy in 400 B.C. Modern BLT, however, is informed by neuroscience that emerged in the 1980s.

Our bodies have a master central clock called the suprachiasmatic nucleus (SCN) located in the hypothalamus. The SCN orchestrates nearly all our daily physiological rhythms. Light primarily detected by specialized cells in our retina send signals directly back to the SCN helping to synchronize our internal clocks with the external light-dark cycle. When these light cues become irregular, our circadian clock can get erratic affecting everything from sleep-wake cycles to mood. But it’s not just about the SCN.

Emerging evidence suggests that light’s antidepressant effects might also work through other brain centers either in parallel with or even bypassing the SCN. Studies even from non-human models, and yes, we desperately need more human data here, are showing that light signals directly influence regions involved in mood regulation like the prefrontal cortex and brainstem nuclei which are rich in serotonin and noradrenaline pathways.

This tells us that light isn’t just about sleep. It’s directly impacting those mood circuits we often target with medication.

Efficacy of BLT in Bipolar Depression

The ISBD Task Force concluded that adjunctive BLT is likely an efficacious acute treatment for bipolar depression, supported by high-quality evidence. Adding BLT to existing mood stabilizers can:

• Significantly reduce depressive symptoms
• Improve overall global functioning
• Enhance sleep quality, cognitive performance, and anxiety

BLT Works for Non-Seasonal Depression

While bright light therapy is a primary treatment for seasonal depression, recent meta-analyses show its effectiveness for both seasonal and non-seasonal bipolar depressive episodes. And importantly, the data show a good safety profile with lower manic switch rates than pharmaceutical antidepressants.

Implementing BLT in Clinical Practice

Before initiating BLT, conduct a thorough diagnostic evaluation:

• Assess 24-hour light exposure
• Evaluate habitual sleep-wake times
• Consider general lifestyle and schedule constraints

For bipolar I patients, an anti-manic agent must be stable for 2-4 weeks before starting BLT. For bipolar II, mood stabilizer coverage depends on clinical judgment.

Contraindications include:

• Acute recent manic episodes
• Recent hypomania
• Mixed symptoms
• Rapid cycling

Patients with retinal diseases or using certain photosensitizing medications (like sulfonamides or St. John’s wort) need a comprehensive ophthalmologic exam first.

BLT Device Specifications

Recommend a bright white UV-filtered light box. UV wavelengths are unnecessary and can be harmful. Key specifications:

• Intensity: 5,000–10,000 lux
• Distance: ~12–13 inches from eyes
• Size: at least 12 × 14 inches
• Position: slightly above eye level, angled down
• Lighting: diffuse, low glare

Advise patients not to stare directly into the light.

BLT Timing and Duration

Ideal timing: Morning (7-9 am) or midday (12-2:30 pm)

Start low and go slow:

• Begin with 15 minutes daily
• Increase by 15 minutes weekly
• Aim for 45-60 minutes daily by week 4

For 5000 lux intensity, aim for one hour. For 10,000 lux, aim for 30 minutes.

Clinical improvement is typically seen within 1-2 weeks, with remission expected by 4-6 weeks. This is often faster than pharmaceutical antidepressants. Once remission is achieved, a patient can continue bright light therapy for at least a year to maintain benefits and prevent relapse. You can often reduce the intensity or duration for maintenance.

Monitoring Recommendations

Regular monitoring is crucial. You can use patient-centered outcome assessments like the PHQ-9 for depression, GAD-7 for anxiety and the Young Mania Rating Scale for mania to track progress and identify any early warning signs of mood worsening or a switch.

If a patient experiences worsening depression, increasing suicidal thoughts or mood destabilization, advise them to immediately reduce or stop the light and contact you.

Limitations and Challenges

While acute evidence is strong, long-term maintenance data are limited. Many mechanistic studies rely on non-human models. Clinical trials vary in sample size, treatment parameters, and duration, limiting generalizability.

Finally, there are real-world implementation challenges. The cost of light therapy devices ranging from $100 up to $300, lack of reimbursement in many healthcare systems for these lights and patient adherence can be significant barriers especially in outpatient settings. Device standardization is also an issue with variability in lux output, UV filtering and diffusion quality. These factors are even more pronounced in low- and middle-income countries.

Integrate BLT into Patient’s Daily Routines

BLT isn’t a set it and forget sort of treatment. It requires active engagement and careful monitoring from both clinician and patient. We need to explore feasible ways to integrate it into patients’ daily routines. I like discussing with patients what time of day they envision using the light and what regular activities they might do during it, such as reading, answering emails, applying makeup, or listening to music.

Encouraging healthy lifestyle habits like consistent sleep schedules, regular exercise, limiting evening bright light exposure and spending time outdoors can significantly complement bright light therapy and enhance long-term outcomes.

Conclusion: BLT’s Potential in Bipolar Depression

Bright light therapy represents a valuable, effective and generally really well-tolerated adjunctive treatment for bipolar depression. It can lead to faster remission than medication alone and empower patients by giving them an active role in their recovery.

While more research is needed, especially on long-term maintenance and implementation barriers, the current evidence for BLT is compelling. My hope is that this discussion encourages you to consider BLT more readily in your practice. Let’s work together to bridge that gap between research and clinical application providing our patients with every tool available to navigate the complexities of bipolar disorder and achieve lasting well-being.

Abstract

Light therapy for bipolar disorders: Clinical recommendations from the international society for bipolar disorders (ISBD) Chronobiology and Chronotherapy Task Force

Pierre A. Geoffroy, Laura Palagini, Tone E. G. Henriksen, Patrice Bourgin, Corrado Garbazza, Claude Gronfier ,Yuichi Esaki, Diego C. Fernandez, Raymond W. Lam, Heon-Jeong Lee, Michel Lejoyeux, Julia Maruani, Klaus Martiny, Greg Murray, Rixt F. Riemersma-Van Der Lek, Philipp Ritter, Peter F.J. Schulte, Daniel J. Smith, Michael Terman, Jamie M. Zeitzer &Dorothy K. Sit.

The International Society for Bipolar Disorders (ISBD) Chronobiology and Chronotherapy Task Force conducted a comprehensive review to deliver concise evidence-based recommendations on the use of bright light therapy (BLT) for bipolar disorder (BD). Adjunctive BLT is likely an efficacious acute treatment for bipolar depression as implicated by higher quality evidence. The position of maintenance BLT for relapse prevention awaits further investigation. Protocols of effective BLT in BD are similar to parameters indicated for treatment of seasonal and non-seasonal major depressive disorder. Anti-manic prophylaxis (especially for BD-I) and clinical monitoring are recommended with initiation of and ongoing light treatment. Administer BLT daily, preferably in the morning or at mid-day. If mornings are prohibitive, then mid-day exposure, implemented to avoid excessively early wake times, is an acceptable alternative. Informed by the literature, target 30 min/day of BLT exposure. Patients wary of emergent hypomania or partial responders, can initiate 15 min/day and increase by 15 min each week to full response (or 30–60 min/day by the fourth week). Consider patient centred outcome assessments to evaluate mood response, safety and side effects. Clinical improvement is typically observed within 1–2 weeks, with response/remission expected by 4–6 weeks. Integration of BLT with other chronotherapeutic strategies may enhance long-term efficacy.

Keywords:

Bipolar disorder, depression, seasonal affective disorder, light therapy, phototherapy, and chronotherapy

Reference

Geoffroy, P. A., Palagini, L., Henriksen, T. E. G., Bourgin, P., Garbazza, C., Gronfier, C., … Sit, D. K. (2025). Light therapy for bipolar disorders: Clinical recommendations from the international society for bipolar disorders (ISBD) Chronobiology and Chronotherapy Task Force. Dialogues in Clinical Neuroscience, 27(1), 249–264.